Fny Investment Advisers, LLC Regeneron Pharmaceuticals, Inc. Transaction History

Fny Investment Advisers, LLC

  • $208 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2019

Oct 25, 2019
SELL
$273.46 - $318.39 $1,914 - $2,228
-7 Closed
0 $0
Q2 2019

Jul 24, 2019
BUY
$299.6 - $414.82 $2,097 - $2,903
7 New
7 $2,000
Q4 2018

Jan 22, 2019
SELL
$335.82 - $403.04 $12,089 - $14,509
-36 Closed
0 $0
Q3 2018

Oct 29, 2018
BUY
$351.14 - $408.51 $12,641 - $14,706
36 New
36 $14,000

Others Institutions Holding REGN

# of Institutions
1,532
Shares Held
84.1M
Call Options Held
1.22M
Put Options Held
1.51M
View Full List

About REGENERON PHARMACEUTICALS, INC.

REGN Quotes by TradingView
  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $80.3B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Fny Investment Advisers, LLC Portfolio

Follow Fny Investment Advisers, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fny Investment Advisers, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email